Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Clin Pharmacol Ther. 2020 Dec 17;109(6):1528–1537. doi: 10.1002/cpt.2122

Figure 1.

Figure 1.

Analysis workflow. Our analysis comprises three data types, data imputed from genotype arrays, exome sequencing data, and an integrated call set that combines both. We phase all datasets using statistical phasing with Eagle2. We then generate pharmacogenetic alleles for all samples using PGxPOP and generate a report of the matching star allele, the variants contributing to that call, and the resulting phenotype.